Frisch Financial Group, Inc. Eli Lilly & CO Transaction History

Frisch Financial Group, Inc.

$333 Million
Q3 2024

A detailed history of Frisch Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 2,054 shares of LLY stock, worth $1.62 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

2,054

Previous 2,423 15.23%

Holding current value

$1.62 Million

Previous $2.19 Million 17.05%

% of portfolio

0.55%

Previous 0.66%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $284,919 - $354,247	-369 Reduced 15.23%	2,054 $1.82 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $189,915 - $238,168	262 Added 12.12%	2,423 $2.19 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $286,624 - $383,463	-484 Reduced 18.3%	2,161 $1.68 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $46,216 - $54,483	88 Added 3.44%	2,645 $1.54 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $240,256 - $321,251	-685 Reduced 21.13%	2,557 $1.2 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $8,697 - $10,214	28 Added 0.87%	3,242 $1.11 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $66,882 - $77,931	208 Added 6.92%	3,214 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $10,080 - $11,487	34 Added 1.14%	3,006 $972,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1,393 - $1,636	5 Added 0.17%	2,972 $964,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $1,408 - $1,749	6 Added 0.2%	2,967 $850,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $1,349 - $1,674	6 Added 0.2%	2,961 $818,000
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $654,828 - $805,858	2,955 New	2,955 $683,000
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $653,276 - $803,949	-2,948 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $1,083 - $1,401	6 Added 0.2%	2,948 $677,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $35,328 - $45,734	215 Added 7.88%	2,942 $550,000
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $1,043 - $1,381	8 Added 0.29%	2,727 $460,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $6,872 - $7,949	-47 Reduced 1.7%	2,719 $403,000
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $1,091 - $1,313	8 Added 0.29%	2,766 $454,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $46,548 - $57,613	-391 Reduced 12.42%	2,758 $383,000
Q4 2019 Jan 28, 2020	BUY	$106.92 - $132.43 $43,730 - $54,163	409 Added 14.93%	3,149 $414,000
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $961 - $1,045	9 Added 0.33%	2,740 $306,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $66,584 - $77,721	-601 Reduced 18.04%	2,731 $303,000
Q1 2019 May 06, 2019	BUY	$111.31 - $131.02 $23,931 - $28,169	215 Added 6.9%	3,332 $432,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $330,090 - $369,800	3,117 New	3,117 $361,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.

Account

Frisch Financial Group, Inc. Eli Lilly & CO Transaction History